Research Topics
| V SteenSummaryAffiliation: Georgetown University Country: USA Publications
| Collaborators
|
Detail Information
Publications
Pulmonary arterial hypertension and severe pulmonary fibrosis in systemic sclerosis patients with a nucleolar antibodyVirginia D Steen
Department of Medicine, Division of Rheumatology, Allergy and Immunology, Georgetown University, 3800 Reservoir Road, Washington, DC 20007, USA
J Rheumatol 34:2230-5. 2007..Our study focuses on lung disease in patients with a nucleolar antibody in comparison to other scleroderma-specific autoantibodies...
A clinical and serologic comparison of African American and Caucasian patients with systemic sclerosisVirginia Steen
Georgetown University School of Medicine, Washington, DC 20007, USA
Arthritis Rheum 64:2986-94. 2012....
Digital ulcers: overt vascular disease in systemic sclerosisV Steen
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
Rheumatology (Oxford) 48:iii19-24. 2009....- Exercise-induced pulmonary arterial hypertension in patients with systemic sclerosisVirginia Steen
Georgetown University School of Medicine, Georgetown University, Department of Medicine, LL Gorman, Washington, DC 20007, USA
Chest 134:146-51. 2008..This study looks at the use of an exercise echocardiogram in identifying patients who may have PAH and may be candidates for early therapeutic intervention... - The many faces of sclerodermaVirginia D Steen
Department of Medicine, Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
Rheum Dis Clin North Am 34:1-15; v. 2008..These antibodies should be used in performing clinical trials and in doing genetic and basic research. Hopefully, these scleroderma antibodies will lead to a better understanding of the pathogenesis of scleroderma... - Pregnancy in sclerodermaVirginia D Steen
Department of Medicine, Georgetown University Medical Center, Washington, DC 20007, USA
Rheum Dis Clin North Am 33:345-58, vii. 2007..All patients who become pregnant during this high-risk time should be monitored extremely carefully, particularly for renal crisis... - Changes in causes of death in systemic sclerosis, 1972-2002Virginia D Steen
Georgetown University, Washington, DC 20007, USA
Ann Rheum Dis 66:940-4. 2007..Survival of scleroderma has changed since the renal crisis treatment has become possible... - Treatment of systemic sclerosisV D Steen
Department of Medicine, Georgetown University, Washington, DC, USA
Am J Clin Dermatol 2:315-25. 2001..Although an overall remittive therapy has not yet been determined, new, potentially useful agents are being investigated... - Targeted therapy for systemic sclerosisVirginia Steen
Medstar Georgetown University, Division of Rheumatology, Immunology, and Allergy, 3800 Reservoir Road NW, LL Gorman, Washington, DC 20007, USA
Autoimmun Rev 5:122-4. 2006..All of these factors are influenced by unknown inciting agents and the permissive genetic background... - The lung in systemic sclerosisVirginia D Steen
Georgetown University Medical Center, 3800 Reservoir Road, LL Kober Cogan Building, Washington, DC 20007, USA
J Clin Rheumatol 11:40-6. 2005 - Autoantibodies in systemic sclerosisVirginia D Steen
Department of Medicine, Georgetown University, Washington, DC 2007, USA
Semin Arthritis Rheum 35:35-42. 2005..To describe the clinical, laboratory, and prognostic features associated with the scleroderma-specific autoantibodies... - Predictors of end stage lung disease in systemic sclerosisV Steen
Georgetown University, Washington DC, USA
Ann Rheum Dis 62:97-9. 2003 - The heart in systemic sclerosisVirginia Steen
Georgetown University, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
Curr Rheumatol Rep 6:137-40. 2004..More extensive evaluation of the conduction and the arrhythmia ablative therapy has helped manage these life-threatening complications... - Assessment of kidney involvementV D Steen
Georgetown University School of Medicine, Division of Rheumatology, Allergy and Clinical Immunology, 3800 Reservoir Road, LL Gorman, Washington, DC 20007, USA
Clin Exp Rheumatol 21:S29-31. 2003..In clinical investigations SSc patients developing arterial hypertension after the disease onset (new onset hypertension) without SRC should also be reported... - Scleroderma renal crisisVirginia D Steen
Division of Rheumatology, Immunology, and Allergy, Department of Medicine, Georgetown University, 3800 Reservoir Road, NW LL Gorman, Washington, DC 20007, USA
Rheum Dis Clin North Am 29:315-33. 2003..Prompt diagnosis and early, aggressive initiation of therapy with ACE inhibitors will result in the most optimal outcome... - Childhood onset systemic sclerosis: classification, clinical and serologic features, and survival in comparison with adult onset diseaseKenneth Scalapino
Department of Medicine, University of Pittsburgh School of Medicine, Pittsburgh, PA 15261, USA
J Rheumatol 33:1004-13. 2006.... - Kidney disease other than renal crisis in patients with diffuse sclerodermaVirginia D Steen
Georgetown University, Washington, DC 20007, USA
J Rheumatol 32:649-55. 2005..These patients with scleroderma should be carefully evaluated for non-scleroderma causes of kidney disease... - Gastric antral vascular ectasia in systemic sclerosis: demographics and disease predictorsKristin M Ingraham
Division of Rheumatology, Georgetown University, Washington, DC, USA
J Rheumatol 37:603-7. 2010.... - Development of a provisional core set of response measures for clinical trials of systemic sclerosisD Khanna
Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, University of California at Los Angeles, California 90095, USA
Ann Rheum Dis 67:703-9. 2008..To develop a provisional core set of response measures for clinical trials of systemic sclerosis (SSc)... - Responsiveness of the SF-36 and the Health Assessment Questionnaire Disability Index in a systemic sclerosis clinical trialDinesh Khanna
Division of Rheumatology, Department of Medicine, David Geffen School of Medicine, Los Angeles, California, USA
J Rheumatol 32:832-40. 2005.... - Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti-topoisomerase I antibodyAchini Perera
University of Pittsburgh School of Medicine, 3500 Terrace Street, Pittsburgh, PA 15261, USA
Arthritis Rheum 56:2740-6. 2007.... - A comparison between anti-Th/To- and anticentromere antibody-positive systemic sclerosis patients with limited cutaneous involvementGhaith M Mitri
HealthStar Physicians, Jefferson City, Tennessee, USA
Arthritis Rheum 48:203-9. 2003.... - Lung transplantation in scleroderma compared with idiopathic pulmonary fibrosis and idiopathic pulmonary arterial hypertensionLionel Schachna
Johns Hopkins University, Baltimore, Maryland 21224, USA
Arthritis Rheum 54:3954-61. 2006..Lung transplantation may represent a viable therapeutic option to consider for patients with end-stage lung disease due to scleroderma... - Correlation of the degree of dyspnea with health-related quality of life, functional abilities, and diffusing capacity for carbon monoxide in patients with systemic sclerosis and active alveolitis: results from the Scleroderma Lung StudyDinesh Khanna
David Geffen School of Medicine, University of California, Los Angeles, USA
Arthritis Rheum 52:592-600. 2005.... - Clinical trials in systemic sclerosis: lessons learned and outcomesMarco Matucci-Cerinic
Division of Medicine and Surgery, Division of Medicine I and Rheumatology, Villa Monna Tessa, Viale Pieraccini, I 50139 Florence, Italy
Arthritis Res Ther 9:S7. 2007....